Biotricity Inc. provided earnings guidance for the first fiscal quarter ended June 30, 2023. For the period, the company expects to report an approximate increase in revenue which represents growth of over 40% YOY from the corresponding prior year quarter and expects to achieve continued reduction in expenses.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | -2.34% | -14.38% | +8.70% |
Apr. 26 | Biotricity Inc. Announces High Demand for Its Latest Device, Biotres Pro | CI |
Apr. 19 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
+8.70% | 12.12M | |
+4.07% | 3.48B | |
-10.90% | 156M | |
-15.69% | 81.85M | |
+30.43% | 59.71M |
- Stock Market
- Equities
- BTCY Stock
- News Biotricity, Inc.
- Biotricity, Inc. Provides Earnings Guidance for the First Fiscal Quarter Ended June 30, 2023